You should keep in mind this is compared to $60,000 for Taxotere, the only treatment currently available to patients this sick. In virtually all cases treatment with Taxotere will add another $30K+ in support care expense (hospitalization, follow-up care, medication, etc.) to treat the added sickness caused by chemotherapy. The only side effect or additional care patients using Provenge will have to endure will be slight fever, rash, or a regular oncology visit. In the end it costs the same and patients live longer, and with dignity.
I work for Dendreon and today has been one of the greatest of my life - I am proud to work for a company that truly puts patients first. It gives me hope to see science and logic prevail in our increasingly skeptical and cynical world. Like all things demand for the science will improve process and reduce price, but we should focus on the breakthrough, both bureaucratic and scientific, that Provenge represents.